Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: results of a multicenter, collaborative trial in Latin America (2001)
- Authors:
- Autor USP: GATTAZ, WAGNER FARID - FM
- Unidade: FM
- Subjects: ANTIPSICÓTICOS (EFEITOS ADVERSOS); AMÉRICA LATINA
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2001
- Source:
- Título: Journal of Clinical Pychopharmacology
- ISSN: 0271-0749
- Volume/Número/Paginação/Ano: v. 21, n. 4, p. 375-381, aug. 2001
-
ABNT
SILVA, Jorge A. Costa e et al. Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: results of a multicenter, collaborative trial in Latin America. Journal of Clinical Pychopharmacology, v. 21, n. 4, p. 375-381, 2001Tradução . . Disponível em: http://gateway2.ovid.com/ovidweb.cgi. Acesso em: 13 fev. 2026. -
APA
Silva, J. A. C. e, Alvarez, N., Mazzotti, G., Gattaz, W. F., Ospina, J., Larach, V., et al. (2001). Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: results of a multicenter, collaborative trial in Latin America. Journal of Clinical Pychopharmacology, 21( 4), 375-381. Recuperado de http://gateway2.ovid.com/ovidweb.cgi -
NLM
Silva JAC e, Alvarez N, Mazzotti G, Gattaz WF, Ospina J, Larach V, Starkstein S, Oliva D, Cousins L, Tohen M, Taylor CC, Wang J, Tran PV. Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: results of a multicenter, collaborative trial in Latin America [Internet]. Journal of Clinical Pychopharmacology. 2001 ; 21( 4): 375-381.[citado 2026 fev. 13 ] Available from: http://gateway2.ovid.com/ovidweb.cgi -
Vancouver
Silva JAC e, Alvarez N, Mazzotti G, Gattaz WF, Ospina J, Larach V, Starkstein S, Oliva D, Cousins L, Tohen M, Taylor CC, Wang J, Tran PV. Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: results of a multicenter, collaborative trial in Latin America [Internet]. Journal of Clinical Pychopharmacology. 2001 ; 21( 4): 375-381.[citado 2026 fev. 13 ] Available from: http://gateway2.ovid.com/ovidweb.cgi - Atividade de subtipos de 'PLA IND. 2' em neurônios primários mantidos em cultura
- Inibição da fosfolipase 'A IND. 2' e hiperfosforilação da proteína Tau em culturas primárias de neurônios corticais e hipocampais
- GSK3beta em plaquetas de indivíduos com doença de Alzheimer e comprometimento cognitivo leve
- Lítio inibe a transcrição de GSK3b: implicações para a doença de Alzheimer
- Leukocyte telomerase activity and antidepressant efficacy in bipolar disorder
- Increased phospholipase A2 activity in schizophrenia with absent response to niacin
- Hippocampal serotonin depletion is related to the presence of generalized tonic-clonic seizures, but not to psychiatric disorders in patients with temporal lobe epilepsy
- Detecção da translocação T (11;18) AP12/MALTI associada a linfoma malt gástrico em especimens de biópsia pelas técnicas de RT-PCR e FISH
- CYP2C9 Intermediate and Poor Metabolizers are More Prevalent in a Sample of Refractory Mood Disorders Patients Undergoing ECT
- Chronic inhibition of brain phospholipase A2 in rats as a model to investigate Alzheimer-related alterations: a preliminary study
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
